Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a42e8f1e8756e50138751c9644ca47e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_855459739e127e828c2ad9f72d028e9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ffa3f9d6b87e15e0a1551fb129b531 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f70b95d690ea6434c2e4fc0e930dff3 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
filingDate |
2011-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bf0bf486dd485554b65d946b016263f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_769f952f4e38506a5afe7ae4ce5ba694 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af64f04f82b74e5d6f0ceb5877e926e4 |
publicationDate |
2015-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9120802-B2 |
titleOfInvention |
Pyrimidine derivatives and their use in the treatment of respiratory diseases such as COPD |
abstract |
Compounds of formula (I) are inhibitors of neutrophil elastase, wherein A is C—R 1 or N; —X 1 —X 2 — is CR 15 ═N— or —NR 19 —CO—; and R 1 -R 6 , R 15 and R 16 are as defined in the claims. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9487528-B2 |
priorityDate |
2010-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |